Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|33|5909-5928

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.33, 2013-10, pp. : 5909-5928

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Mechanisms of Atherogenesis and Development of Anti-Atherosclerotic Therapy)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1103-1106

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models to evaluate anti‐atherosclerotic drugs

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 4, 2015-08 ,pp. : 329-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5954-5962

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5873-5882

Bentham Science Publishers

Access to resources Recommend Favorite

Calcium antagonists as anti-atherosclerotic agents

By Gaviraghi G.   Trist D.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 135-146

Informa Healthcare

Access to resources Recommend Favorite